5Tamura S,Nishigaki T,Moriwaki Y,et al.Tumor markers in pleural effeusion diagnosis[J].Cancer,1998,61(2):298-299.
6Muraki M,Tohda Y,Lwanga T,et al.Assessment of serum Cyfra 21-1 in lung cancer[J].Cancer,1996,77:1274-1275.
7Hoefler H,Denk H.Immunohistochemical demonstration of cytokeratins in gastrointestinal carcinoids and their probable precursors cells[J]. Virchows Arch B Cell Pathol,1984,403:235～240.
6Spira A, Ettinger DS. Muhidisciplinary management of lung cancer [J]. N Engl J Med,2004,350(4) :379-392.
7Kawachi R, Nakazato Y,Takei H, et al. Clinical significance of pre- operative carcinoem bryonic antigen level for clinical stage I non- small cell lung cancer: can preoperative cancinoembryonic antigen level predict pathological stage [ J ]. Interact Cardiovasc Thorac Surg,2009,9 (2) :199-202.
8Fukai R,Sakao Y,Sakuraba M,et a/. The prognostic value of carcino- embryonic antigen in TIN1M0 and T2NIMo non-small cell carcinoma of the lung[J]. Eur J Cardiothorac Surg,2{D7,32(3) :440-444.
9Bekci TT, Senol T, Maden E. The efficacy of serum carcinoembry- onic antigen ( CEA), cancer antigen 125 ( CA125 ), carbohyrate an- tigen 19-9(CA19-9) ,carbohydrate antigen 15-3 ( CA15-3 ), alpha- fetoprotein(AFP) and human chorionic gonadotropin(HCG) levels in determining the malignancy of solitary pulmonary nodules [ J ]. J Im Med Res.2009.37(2) :438-445.
10Ando S, Kimura H, Iwai N, et al. Optimal combination of seven tumor markers in prediction of advanced stage at fist examination of patients with non-small cell lung cancer [ J ]. Anticancer Res, 2001,21 (4B) :3085-3092.
